KGKhadra Galaal

Khadra Galaal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Khadra Galaal has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Primary Vaginal Epithelioid Haemangioendothelioma with Pulmonary Metastasis: A case report and review of the literature

    by Anwar Al Shuaili, Huda Kashoob, Zahida Niaz, Nausheen Yaqoob, Khadhra Ahmed J. Galaal, Reem Ahmed Al Mazrouai

    Epithelioid haemangioendothelioma (EHE) is a rare vascular sarcoma of intermediate malignancy. In 2023, a 31-year-old female presented to a tertiary care hospital in Muscat, Oman, with symptoms later diagnosed as primary vaginal EHE. The patient had primary, locally invasive vaginal EHE that subsequently metastasised to the lungs. The patient experienced progression of systemic disease despite chemotherapy and was therefore transitioned to palliative chemotherapy. The clinical, radiological and histopathological findings as well as the diagnostic features that distinguish EHE from its aggressive mimic, epithelioid angiosarcoma, are described in this report. This case highlights the diagnostic challenges, the importance of molecular confirmation and the unpredictable clinical course of this ultra-rare malignancy. To the best of the authors' knowledge, this is the first reported case of primary vaginal EHE.

  • Open Access

    The impact of socioeconomic deprivation on mortality in cervical cancer patients in Cornwall (England)

    by Hannah Donkers, John McGrane, Antonio Eleuteri, Panagiotis Giamougiannis, Ruud Bekkers, Khadra Galaal

    Objectives To assess the association between risk factors, including socioeconomic deprivation, and mortality, recurrence and chemo- or radiation toxicity in cervical cancer patients. Methods Retrospective study of cervical cancer patients diagnosed between January 2007 and July 2018. Patient characteristics and mortality data, including recurrence, were assessed, together with socioeconomic deprivation measures evaluated using the English Indices of Multiple Deprivation. Markov multi-state models were used to model mortality and recurrence, and logistic regression models were used to model chemo- or radiation toxicity. Results Included were 243 women with a median age of 49 years. A total of 57 patients died (23%), of which 41 due to cervical cancer, and 21 (9%) had recurrent disease. Hazard ratios (HR) showed no evidence of association between socioeconomic deprivation and cancer-specific hazard of mortality from diagnosis or recurrence, hazard of mortality due to other causes or hazard of cancer recurrence. Furthermore, there was no evidence of association between socioeconomic deprivation and chemo- or radiation toxicity (bowel, bladder or vaginal stenosis). Conclusions No associations were found between socioeconomic deprivation and cancer mortality or recurrence in cervical cancer patients in the population of Cornwall. In addition, no association was found between socioeconomic deprivation and chemo- or radiation toxicity.

  • Usefulness of microRNA detection in the diagnostics of endometrial cancer

    by Hannah Donkers, Marc Hirschfeld, Daniela Weiß, Thalia Erbes, Markus Jaeger, Johanna M. A. Pijnenborg, Ruud Bekkers, Khadra Galaal, ENITEC‐consortium

    Introduction: MicroRNAs (miRNAs) are noncoding RNAs that regulate gene expression and contribute to the development of cancer. They have been shown to be stable in tissue samples and may be promising diagnostic biomarkers for endometrial cancer.Material and methods: A retrospective cohort study of women diagnosed with endometrial cancer between January 2017 and December 2017 was performed at the Royal Cornwall Hospital. Archived formalin‐fixed paraffin‐embedded samples were obtained from patients with endometrial cancer and healthy women. MicroRNA was isolated and quantitative real‐time polymerase chain reaction was used to detect expression levels of miRNAs.Results: A total of 76 women were included: 36 endometrial cancer patients, 40 healthy controls. A distinct panel of miR‐200a, miR‐200b, miR‐200c, miR‐205, and miR‐182 showed an area under the curve of 0.958, sensitivity 92%, specificity 89%, positive predictive value of 89% (95% CI 82%–94%) and negative predictive value of 91% (95% CI 85%–96%) in diagnosing endometrial cancer. High miR‐182 expression levels were significantly related to high‐grade endometrioid tumors compared with low‐grade tumors.Conclusions: We demonstrated high diagnostic accuracy of miRNA for detecting endometrial cancer. In addition, miRNA contributed to an improvement in distinguishing between high‐grade and low‐grade endometrioid tumors.


  • The role of sarcopenic obesity in high‐grade endometrial cancer

    by Hannah Donkers, Kristine E. Fasmer, John Mcgrane, Johanna M. A. Pijnenborg, Ruud Bekkers, Ingfrid S. Haldorsen, Khadra Galaal

    Objective: To investigate the relationship between obesity and sarcopenia in relation to overall survival (OS) and disease‐specific survival (DSS) in high‐grade endometrial cancer patients.Methods: We conducted a retrospective study in women diagnosed with high‐grade endometrial cancer (EC) between February 2006 and August 2017 in the Royal Cornwall Hospital who had abdominal computerized tomography (CT)‐scan as part of routine staging work‐up. Sarcopenia was assessed by measuring psoas‐, paraspinal‐ and abdominal wall muscles on CT and defined by skeletal muscle index ≤41 cm2/m2. Sarcopenic obesity was defined as sarcopenia combined with body mass index (BMI) ≥30 kg/m2.Results: A total of 176 patients with median age of 70 years and median BMI of 29.4 kg/m2were included in the study. The majority of patients (38%) had endometrioid type histology. Sarcopenia was not associated with OS (P = 0.951) or DSS (P = 0.545) However, in multivariate analysis, sarcopenic obesity was associated with reduced OS in endometrioid endometrial cancer (EEC) patients (P = 0.048).Conclusion: Sarcopenic obesity is associated with OS in high‐grade EEC patients, while sarcopenia without obesity is not related to OS or DSS in high‐grade EC. In non‐endometrioid endometrial cancer, there is no association between sarcopenic obesity and survival.


  • Obesity and visceral fat: Survival impact in high-grade endometrial cancer

    by Hannah Donkers, Kristine E. Fasmer, John Mcgrane, Johanna M.A. Pijnenborg, Ruud Bekkers, Ingfrid S. Haldorsen, Khadra Galaal


  • Open Access

    Diagnostic value of microRNA panel in endometrial cancer: A systematic review

    by Hannah Donkers, Ruud Bekkers, Khadra Galaal

    Https://doi.org/10.18632/oncotarget.27601 Hannah Donkers, Ruud Bekkers, Khadra Galaal


  • Socioeconomic deprivation and survival in endometrial cancer: The effect of BMI

    by H. Donkers, R. Bekkers, L. Massuger, K. Galaal


  • Open Access

    Systematic review on socioeconomic deprivation and survival in endometrial cancer

    by H. Donkers, R. Bekkers, L. Massuger, K. Galaal

    The primary objectives in this review were to (1) assess the association between socioeconomic deprivation and survival in endometrial cancer patients (2) investigate if there is an association between socioeconomic deprivation and peri-operative morbidity in endometrial cancer patients.


  • Open Access

    Trial of intraoperative cell salvage versus transfusion in ovarian cancer (TIC TOC): protocol for a randomised controlled feasibility study

    by Khadra Galaal, Alberto Lopes, Colin Pritchard, Andrew Barton, Jennifer Wingham, Elsa M R Marques, John Faulds, Joanne Palmer, Patricia Jane Vickery, Catherine Ralph, et al.

    Introduction Ovarian cancer is the leading cause of death from gynaecological cancer, with more than 7000 new cases registered in the UK in 2014. In patients suitable for surgery, the National Institute of Health and Care Excellence guidance for treatment recommends surgical resection of all macroscopic tumour, followed by chemotherapy. The surgical procedure can be extensive and associated with substantial blood loss which is conventionally replaced with a donor blood transfusion. While often necessary and lifesaving, the use of donor blood is associated with increased risks of complications and adverse surgical outcomes. Intraoperative cell salvage (ICS) is a blood conservation strategy in which red cells collected from blood lost during surgery are returned to the patient thus minimising the use of donor blood. This is the protocol for a feasibility randomised controlled trial with an embedded qualitative study and feasibility economic evaluation. If feasible, a later definitive trial will test the effectiveness and cost-effectiveness of ICS reinfusion versus donor blood transfusion in ovarian cancer surgery. Methods and analysis Sixty adult women scheduled for primary or interval ovarian cancer surgery at participating UK National Health Service Trusts will be recruited and individually randomised in a 1:1 ratio to receive ICS reinfusion or donor blood (as required) during surgery. Participants will be followed up by telephone at 30 days postoperatively for adverse events monitoring and by postal questionnaire at 6 weeks and 3 monthly thereafter, to capture quality of life and resource use data. Qualitative interviews will capture participants’ and clinicians’ experiences of the study. Ethics and dissemination This study has been granted ethical approval by the South West–Exeter Research Ethics Committee (ref: 16/SW/0256). Results will be disseminated via peer-reviewed publications and will inform the design of a larger trial. Trial registration number ISRCTN19517317.


  • Top Cited Papers

    Laparoscopy versus laparotomy for the management of early stage endometrial cancer

    by Khadra Galaal, Hannah Donkers, Andrew Bryant, Alberto D Lopes

    Background This is an update of a previous Cochrane Review published in 2012, Issue 9. Surgery for endometrial cancer (hysterectomy with removal of both fallopian tubes and ovaries) is performed through laparotomy. It has been suggested that the laparoscopic approach is associated with a reduction in operative morbidity. Over the last two decades there has been a steady increase of the use of laparoscopy for endometrial cancer. This review investigated the evidence of benefits and harms of laparoscopic surgery compared with laparotomy for presumed early stage endometrial cancer. Objectives To compare overall survival (OS) and disease free survival (DFS) for laparoscopic surgery versus laparotomy in women with presumed early stage endometrial cancer. Search methods For this update, we searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2018, Issue 5) in the Cochrane Library, MEDLINE via Ovid (April 2012 to June 2018) and Embase via Ovid (April 2012 to June 2018). We also searched registers of clinical trials, abstracts of scientific meetings and reference lists of included studies. The trial registers included NHMRC Clinical Trials Register, UKCCCR Register of Cancer Trials, Meta‐Register and Physician Data Query Protocol. Selection criteria Randomised controlled trials (RCTs) comparing laparoscopy and laparotomy for early stage endometrial cancer. Data collection and analysis We independently abstracted data and assessed risk of bias. We used hazard ratios (HRs) for OS and recurrence free survival (RFS), risk ratios (RR) for severe adverse events and mean differences (MD) for continuous outcomes in women who received laparoscopy or laparotomy with 9% confidence intervals (CI). These were pooled in random‐effects meta‐analyses. Main results We identified one new study in this update of the review. The review contains nine RCTs comparing laparoscopy with laparotomy for the surgical management of early stage endometrial cancer. All nine studies met the inclusion criteria and assessed 4389 women at the end of the studies. Six studies assessing 3993 participants with early stage endometrial cancer found no significant difference in the risk of death between women who underwent laparoscopy and women who underwent laparotomy (HR 1.04, 95% 0.86 to 1.25; moderate‐certainty evidence) and five studies assessing 3710 participants found no significant difference in the risk of recurrence between the laparoscopy and laparotomy groups (HR 1.14, 95% CI 0.90 to 1.43; moderate‐certainty evidence). There was no significant difference in the rate of perioperative death; women requiring a blood transfusion; and bladder, ureteric, bowel and vascular injury. However, one meta‐analysis of three studies found that women in the laparoscopy group lost significantly less blood than women in the laparotomy group (MD –106.82 mL, 95% CI –141.59 to –72.06; low‐certainty evidence). A further meta‐analysis of two studies, which assessed 3344 women and included one very large trial of over 2500 participants, found that there was no clinical difference in the risk of severe postoperative complications in women in the laparoscopy and laparotomy groups (RR 0.78, 95% CI 0.44 to 1.38). Most studies were at moderate risk of bias. All nine studies reported hospital stay and results showed that on average, laparoscopy was associated with a significantly shorter hospital stay. Authors' conclusions This review found low to moderate‐certainty evidence to support the role of laparoscopy for the management of early endometrial cancer. For presumed early stage primary endometrioid adenocarcinoma of the endometrium, laparoscopy is associated with similar OS and DFS. Furthermore, laparoscopy is associated with reduced operative morbidity and hospital stay. There is no significant difference in severe postoperative morbidity between the two modalities. The certainty of evidence for OS and RFS was moderate and was downgraded for unclear risk of bias profiles and imprecision in effect estimates. However, most studies used adequate methods of sequence generation and concealment of allocation so studies were not prone to selection bias. Adverse event outcomes were downgraded for the same reasons and additionally for low event rates and low power thus these outcomes provided low‐certainty evidence.